2026-2034年全球体外诊断医疗设备（IVD）市场规模、份额、趋势和成长分析报告（心臟病学和神经病学领域）

预计心臟病学和神经病学领域的体外诊断（IVD）市场将从 2025 年的 246.7 亿美元增长到 2034 年的 563 亿美元，2026 年至 2034 年的复合年增长率为 9.6%。

由于心血管疾病、中风和神经退化性疾病的发生率不断上升，体外诊断（IVD）在心臟病学和神经病学领域的市场正在扩张。人口老化和久坐的生活方式加剧了疾病发生率的上升。透过先进的生物标记检测进行早期诊断，对于改善患者的治疗效果至关重要。

关键成长要素包括分子诊断、就地检验和生物标记发现等领域的技术进步。公众健康意识的提高和预防性筛检计画的扩展正在加速心血管和神经系统疾病的早期发现。诊断设备製造商和医疗服务提供者之间的研究与合作正在加速技术创新。

未来，个人化医疗和人工智慧驱动的诊断工具有望变革疾病管理。随着医疗保健覆盖范围的扩大，新兴市场将带来巨大的机会。随着对快速、准确和微创诊断解决方案的需求不断增长，心臟病学和神经病学领域的体外诊断（IVD）市场预计将实现长期成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球体外诊断医疗设备（IVD）市场（心臟病学和神经病学）：按产品类型划分

• 市场分析、洞察与预测
• 装置
• 试剂和耗材
• 软体和服务

第五章 全球体外诊断医疗设备（IVD）市场－心臟病学和神经病学：按技术划分

• 市场分析、洞察与预测
• 免疫检测
• 分子诊断
• 血液学
• 其他的

第六章 全球体外诊断医疗设备（IVD）市场在心臟病学和神经病学领域的应用：按最终用途划分

• 市场分析、洞察与预测
• 医院
• 临床检查室
• 其他的

第七章 全球体外诊断医疗设备（IVD）市场－心臟病学和神经病学：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • Siemens Healthineers AG
  • Quest Diagnostics Incorporated
  • Abbott
  • BD
  • Bio-Rad Laboratories Inc
  • Beckman Coulter Inc

The IVD In Cardiology And Neurology Market size is expected to reach USD 56.30 Billion in 2034 from USD 24.67 Billion (2025) growing at a CAGR of 9.6% during 2026-2034.

The in vitro diagnostics (IVD) market in cardiology and neurology is expanding due to the increasing prevalence of cardiovascular diseases, stroke, and neurodegenerative disorders. Rising aging populations and sedentary lifestyles are contributing to higher disease incidence. Early diagnosis through advanced biomarker testing is playing a crucial role in improving patient outcomes.

Key growth drivers include technological advancements in molecular diagnostics, point-of-care testing, and biomarker discovery. Increased healthcare awareness and preventive screening programs are encouraging early detection of heart and neurological conditions. Investments in research and collaboration between diagnostic companies and healthcare providers are accelerating innovation.

In the future, personalized medicine and AI-driven diagnostic tools are expected to transform disease management. Emerging markets will present significant opportunities due to expanding healthcare access. As the demand for rapid, accurate, and minimally invasive diagnostic solutions grows, the IVD market in cardiology and neurology is set for long-term expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Instruments
• Reagents & Consumables
• Software And Services

By Technology

• Immunoassays
• Molecular Diagnostics
• Hematology
• Others

By End-use

• Hospitals
• Clinical Laboratories
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, F HoffmannLa Roche Ltd, Sysmex Corporation, Siemens Healthineers AG, Quest Diagnostics Incorporated, Abbott, BD, BioRad Laboratories Inc, Beckman Coulter Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software And Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Technology
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Technology
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Technology
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Technology
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Technology
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 F. Hoffmann-La Roche Ltd
  • 9.2.3 Sysmex Corporation
  • 9.2.4 Siemens Healthineers AG
  • 9.2.5 Quest Diagnostics Incorporated
  • 9.2.6 Abbott
  • 9.2.7 BD
  • 9.2.8 Bio-Rad Laboratories Inc
  • 9.2.9 Beckman Coulter Inc